2015
DOI: 10.1016/j.ejpb.2015.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Chitosan as a starting material for wound healing applications

Abstract: Abstract:Chitosan and its derivatives have attracted great attention due to their properties beneficial for application to wound healing. The main focus of the present review is to summarize studies involving chitosan and its derivatives, especially N,N,N-trimethylchitosan (TMC), N,O-carboxymethyl-chitosan (CMC) and O-carboxymethyl-N,N,Ntrimethyl-chitosan (CMTMC), used to accelerate wound healing. Moreover, formulation strategies for chitosan and its derivatives, as well as their in vitro, in vivo and clinical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
234
0
11

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 488 publications
(247 citation statements)
references
References 111 publications
2
234
0
11
Order By: Relevance
“…In vitro studies revealed that chitosan and some of its water soluble derivatives have antifungal activity and may be used for wound healing purposes [5,[8][9][10][11]. According to these findings, we considered in this study 14 low molecular weight WSDC known to be useful for wound healing.…”
Section: Methodsologymentioning
confidence: 99%
See 1 more Smart Citation
“…In vitro studies revealed that chitosan and some of its water soluble derivatives have antifungal activity and may be used for wound healing purposes [5,[8][9][10][11]. According to these findings, we considered in this study 14 low molecular weight WSDC known to be useful for wound healing.…”
Section: Methodsologymentioning
confidence: 99%
“…As pharmaceutical applications, literature data reveal that chitosan and WSDC are used as carriers for radioactive elements, carriers for drug delivery and release systems and they have antimicrobial properties [2]. Some WSDC are used to accelerate wound healing [5]. Despite literature data revealing their use in biomedical applications, chitosan and its water soluble derivatives are not approved by the US Food and Drug Administration (FDA) for drug delivery, they are only approved to be used for wound healing [6] and as dietary additives in Japan, Italy and Finland [7].…”
Section: Introductionmentioning
confidence: 99%
“…Biopolymers, such as the chitin derivative chitosan, have been shown to accelerate wound healing (1) and offer opportunities for scalable manufacturing in the bioprinting industry (2). Traditionally, biopolymers are obtained from natural sources by extraction from the environment and require further downstream processing including, in many cases, the use of harsh chemicals to obtain desired material properties.…”
Section: Context For Polysaccharide-based Biopolymersmentioning
confidence: 99%
“…These biopolymers are examples of polysaccharides that are synthesized by the synthase-dependent pathway where polymerization and translocation processes are performed by a single synthase protein complex (12). Native biosynthetic mechanisms, such as microbial exopolysaccharide (EPS) 1 biosynthesis, serve as a template for biotechnological production of biomaterials. Typically, synthase-dependent pathways favor homopolymer formation, and the polymers are released into the extracellular environment as non-covalently associated EPS fibers.…”
Section: Context For Polysaccharide-based Biopolymersmentioning
confidence: 99%
“…Chitosan have some unique properties such as biodegradability, non-toxicity, antibacterial effect, muco-adhesive properties and biocompatibility (Shakeel et al, 2014). Apart from the antibacterial nature, chitosan also had haemostatic and mucoadhesive properties (Patrulea et al, 2015) which helped in accelerating tissue regeneration and promoting the wound healing (Kifune, 1992). …”
mentioning
confidence: 99%